Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Side effect
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Frequency of side effects == [[File:Side effects of nicotine.png|thumb|330px|Possible side effects of [[nicotine]]<ref name=Drugs.com>{{cite web|title=Nicotine Side Effects|url=https://www.drugs.com/sfx/nicotine-side-effects.html|publisher=Drugs.com }}</ref><ref name=Schraufnage2014>{{cite journal | vauthors = Schraufnagel DE, Blasi F, Drummond MB, Lam DC, Latif E, Rosen MJ, Sansores R, Van Zyl-Smit R | display-authors = 6 | title = Electronic cigarettes. A position statement of the forum of international respiratory societies | journal = American Journal of Respiratory and Critical Care Medicine | volume = 190 | issue = 6 | pages = 611–8 | date = September 2014 | pmid = 25006874 | doi = 10.1164/rccm.201407-1198PP | s2cid = 43763340 | url = https://figshare.com/articles/journal_contribution/10758143 }}</ref>]] The [[World Health Organization]] and other health organisations characterise the probability of experiencing side effects as:<ref>{{cite web |url=http://www.webmd.com/drugs/2/drug-6111/misoprostol-oral/details/list-sideeffects |title=Common and Rare Side Effects for misoprostol oral}}</ref><ref>{{cite web |url=https://www.who.int/medicines/areas/quality_safety/safety_efficacy/trainingcourses/definitions.pdf |title=Definitions |date=8 May 2007<!--from PDF source-->|url-status=dead|archive-url=https://web.archive.org/web/20160304222413/http://www.who.int/medicines/areas/quality_safety/safety_efficacy/trainingcourses/definitions.pdf |archive-date=2016-03-04}}</ref> * Very common, ≥ <sup>1</sup>'''⁄'''<sub>10</sub> * Common (frequent), <sup>1</sup>'''⁄'''<sub>10</sub> to <sup>1</sup>'''⁄'''<sub>100</sub> * Uncommon (infrequent), <sup>1</sup>'''⁄'''<sub>100</sub> to <sup>1</sup>'''⁄'''<sub>1000</sub> * Rare, <sup>1</sup>'''⁄'''<sub>1000</sub> to <sup>1</sup>'''⁄'''<sub>10000</sub> * Very rare, < <sup>1</sup>'''⁄'''<sub>10000</sub> The [[European Commission]] recommends that the list should contain only effects where there is "at least a reasonable possibility" that they are caused by the drug and the frequency "should represent crude incidence rates (and not differences or relative risks calculated against placebo or other comparator)".<ref>{{Cite web|date=2009-09-01|title=A Guideline on Summary of Product Characteristics|url=https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf|website=[[European Commission]]}}</ref> The frequency describes how often symptoms appear ''after'' taking the drug, without assuming that they were necessarily ''caused by'' the drug. Both healthcare providers<ref>{{cite journal | vauthors = Mühlbauer V, Mühlhauser I | title = Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals | journal = BMC Health Services Research | volume = 15 | issue = 1 | pages = 505 | date = November 2015 | pmid = 26554666 | pmc = 4641349 | doi = 10.1186/s12913-015-1160-1 | doi-access = free }}</ref> and lay people<ref>{{cite journal | vauthors = Mühlbauer V, Prinz R, Mühlhauser I, Wegwarth O | title = Alternative package leaflets improve people's understanding of drug side effects-A randomized controlled exploratory survey | journal = PLOS ONE | volume = 13 | issue = 9 | pages = e0203800 | date = 2018-09-13 | pmid = 30212555 | pmc = 6136776 | doi = 10.1371/journal.pone.0203800 | bibcode = 2018PLoSO..1303800M | doi-access = free }}</ref> misinterpret the frequency of side effects as describing the increase in frequency caused by the drug.
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)